Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It's disappointing that NICE has provisionally been unable to approve...

1 April 2022

Commenting on research published in PLOS Medicine about artificial sweeteners and breast cancer risk, Dr Kotryna Temcinaite, Senior Research...

24 March 2022

On 16 March new findings from the OlympiA phase III trial were presented at a virtual plenary session from the European Society of Medical...

16 March 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said: “We welcome NHS England’s ambition to deliver more rapid cancer diagnosis -...

10 March 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s alarming that in January, for the first time, less than half of women (...

10 March 2022

Background The National Institute for Health and Care Excellence (NICE) has today (Tuesday 8th March 2022) announced its provisional decision not...

8 March 2022

Background The Scottish Medicines Consortium (SMC) has today announced its decision to recommend Trodelvy for use on the NHS in Scotland....

7 March 2022

The National Institute for Health and Care Excellence (NICE) has today (Friday 25 February 2022) announced its decision to recommend breast cancer...

25 February 2022

Key findings: In 2020/21, around 936,000 fewer women in England were screened for breast cancer compared to the previous year.  This is a...

24 February 2022